Klin Farmakol Farm. 2015;29(1):25-28

Pharmacotherapy options in treating patients with diabetic foot syndrome

Pavlína Pi»hová
Interní klinika 2. LF UK a FN Motol, Praha

Diabetic foot syndrome refers to a foot that exhibits pathological changes below the ankle – ulcerations or gangrenes that result directly

from diabetes mellitus. The major factors that can cause the diabetic foot syndrome are diabetic neuropathy, limb ischaemia (angiopathy),

limited joint mobility, and plantar pressure. Healing is complicated by infection. These factors should be targeted in our treatment strategy

that includes pharmacotherapy as well. Antimicrobial, antiplatelet/anticoagulant treatment and drugs improving microcirculation

are mainly used.

Keywords: diabetes mellitus, diabetic foot syndrome, diabetic macroangiopathy, antimicrobial treatment, antiplatelet therapy

Published: March 1, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Pi»hová P. Pharmacotherapy options in treating patients with diabetic foot syndrome. Klin Farmakol Farm. 2015;29(1):25-28.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Allemang MT, Rajani RR, Nelson PR, et al. Prescribing Patterns of Antiplatelet Agents Are Highly Variable After Lower Extremity Endovascular Procedures. Ann Vasc Surg. 2012; Sep 12. pii: S0890-5096 (12)00283-X.
    2. Coello P, Bellmunt S, McGorrian C, et al. Antithrombotic therapy in peripheral artery disease: Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practise Guidelines. CHEST, February 2012; 141(Suppl 2): e669S-e690S. doi: 10.1378/chest.11-2307. Go to original source... Go to PubMed...
    3. Cutting KF, White RJ, Mahoney P, et al. Clinical identification of wound infection: a Delphi approach. In: Position documents - Identifying criteria for wound infection of European Wound Management Association (EWMA), London 2005: 6-10. Go to original source...
    4. Činnost oboru diabetologie, péče o diabetiky v roce 2012. Ústav zdravotnických informací a statistiky, ÚZIS ČR, Aktuální informace č. 24/2013.
    5. Howell-Jones RS, Wilson MJ, Hill KE, et al. A review of the microbiology, antibiotic usage and resistance in chronic skin wounds JAC 2005; 55: 143-149. Go to original source... Go to PubMed...
    6. Lipsky BA, Berendt AR, Deery HG, et al. Diagnosis and treatment of diabetic foot infection. In: IDSA (Infectious Disease Society of America) guidelines 2004, Clinical infectious diseases 2004; 39: 885-910. Go to original source... Go to PubMed...
    7. Piaggessi A., Abbruzzese L, Mattaliano C, et al. Sulodexide as Adjunctive Therapy in Diabetic Foot Patients With Critical Limb Ischemia Treated With Percutaneous Transluminal Angioplasty. Int J Low Extrem Wounds. 2014 May 25; 13(2): 103-109. [Epub ahead of print]. Go to original source... Go to PubMed...
    8. Robertson L, Andras A. Prostanoids for intermittent claudication. Cochrane Database Syst Rev. 2013; 4: CD000986. doi: 10.1002/14651858.CD000986.pub3. Go to original source... Go to PubMed...

    Return to the content


    Clinical Pharmacology and Pharmacy

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.